Caprelsa is a prescription medicine used to treat the symptoms of Medullary Thyroid Cancer. Caprelsa may be used alone or with other medications. Caprelsa belongs to a class of drugs called Antineoplastics, Tyrosine Kinase Inhibitor; Antineoplastics, EGFR Inhibitor.
Initial dose: 300 mg orally once daily.
Duration of therapy: Continue drug until disease progression or unacceptable toxicity occurs.
Use: For the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease.
Take the medicine as soon as you can, but skip the missed dose if your next dose is due in less than 12 hours. Do not take two doses at one time.